Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DTaP vs DT Vaccine in 6-Year-Old Children
NCT05870631Phase 4Unknown
- Start
- May 2023
- Primary completion
- Dec 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of diphtheria + tetanus + acellular pertussis vaccine and diphtheria toxoid adsorbed + tetanus toxoid adsorbed in diphtheria, Tetanus and pertussis (2 arms). Primary endpoints: Seroconversion rate and Seropositive rate. Status: unknown.
02
Drugs
diphtheria + tetanus + acellular pertussis vaccinediphtheria toxoid adsorbed + tetanus toxoid adsorbed
03
Conditions
diphtheriaTetanuspertussis
Beyond the preview
Go deeper on NCT05870631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05870631.